A detailed history of Yousif Capital Management, LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Yousif Capital Management, LLC holds 11,756 shares of AMPH stock, worth $524,787. This represents 0.01% of its overall portfolio holdings.

Number of Shares
11,756
Previous 12,182 3.5%
Holding current value
$524,787
Previous $487,000 17.04%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$36.99 - $50.09 $15,757 - $21,338
-426 Reduced 3.5%
11,756 $570,000
Q2 2024

Jul 31, 2024

SELL
$38.65 - $43.48 $58,941 - $66,307
-1,525 Reduced 11.13%
12,182 $487,000
Q1 2024

Apr 26, 2024

SELL
$42.85 - $63.45 $126,878 - $187,875
-2,961 Reduced 17.76%
13,707 $601,000
Q4 2023

Feb 01, 2024

SELL
$44.49 - $62.93 $47,159 - $66,705
-1,060 Reduced 5.98%
16,668 $1.03 Million
Q3 2023

Oct 30, 2023

SELL
$45.51 - $65.0 $50,243 - $71,760
-1,104 Reduced 5.86%
17,728 $815,000
Q2 2023

Aug 02, 2023

SELL
$35.77 - $58.38 $57,053 - $93,116
-1,595 Reduced 7.81%
18,832 $1.08 Million
Q1 2023

May 02, 2023

SELL
$27.99 - $37.92 $90,127 - $122,102
-3,220 Reduced 13.62%
20,427 $766,000
Q4 2022

Jan 09, 2023

SELL
$27.93 - $31.27 $129,734 - $145,249
-4,645 Reduced 16.42%
23,647 $0
Q3 2022

Nov 04, 2022

BUY
$27.56 - $37.75 $4,492 - $6,153
163 Added 0.58%
28,292 $795,000
Q2 2022

Aug 01, 2022

SELL
$29.79 - $42.29 $90,561 - $128,561
-3,040 Reduced 9.75%
28,129 $979,000
Q1 2022

May 12, 2022

SELL
$22.96 - $36.45 $102,401 - $162,567
-4,460 Reduced 12.52%
31,169 $1.12 Million
Q4 2021

Jan 31, 2022

BUY
$18.14 - $23.29 $646,310 - $829,799
35,629 New
35,629 $830,000

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $2.19B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Yousif Capital Management, LLC Portfolio

Follow Yousif Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yousif Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Yousif Capital Management, LLC with notifications on news.